ClearPoint Neuro (CLPT) Invested Capital (2018 - 2025)
ClearPoint Neuro (CLPT) has disclosed Invested Capital for 13 consecutive years, with $28.0 million as the latest value for Q4 2025.
- Quarterly Invested Capital rose 10.36% to $28.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.0 million through Dec 2025, up 10.36% year-over-year, with the annual reading at $28.0 million for FY2025, 10.36% up from the prior year.
- Invested Capital hit $28.0 million in Q4 2025 for ClearPoint Neuro, up from $15.9 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $58.6 million in Q4 2021 to a low of $15.9 million in Q3 2025.
- Historically, Invested Capital has averaged $38.5 million across 5 years, with a median of $42.3 million in 2023.
- Biggest five-year swings in Invested Capital: skyrocketed 19686.08% in 2021 and later crashed 55.13% in 2025.
- Year by year, Invested Capital stood at $58.6 million in 2021, then decreased by 20.2% to $46.8 million in 2022, then crashed by 33.36% to $31.2 million in 2023, then fell by 18.55% to $25.4 million in 2024, then rose by 10.36% to $28.0 million in 2025.
- Business Quant data shows Invested Capital for CLPT at $28.0 million in Q4 2025, $15.9 million in Q3 2025, and $19.7 million in Q2 2025.